Search Results 781-790 of 18381 for prostate cancer

  1. S1216, Phase III ADT+TAK-700 Vs. ADT+Bicalutamide For Metastatic Prostate Cancer - Mayo Clinic

    The purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen deprivation ...

  2. One size does not fit all in benign prostatic hyperplasia treatment

    The American Urological Association recommends routine prostate cancer screening for all men 55 to 69. Men who are at an increased risk of having an aggressive ...

  3. A Study Of Single Patient Investigational Drug CPI-613 For Use In Treatment-Refractory, Metastatic Prostate Cancer - Mayo Clinic

    About this study. This is a single patient study of an investigational drug CPI-613 for treatment of metastatic prostate cancer. Participation eligibility.

  4. Differences In Immunological Effects Of Vitamin D Replacement Among African American Prostate Cancer Patients With Localized Versus Metastatic Disease - Mayo Clinic

    Also, we will evaluate whether the peripheral blood immune cell function is different in B/AA prostate cancer patients with metastatic disease as compared with ...

  5. As cancer deaths decline, access to care remains a challenge in some communities

    ... prostate cancer," says Dr. Odedina, adding that Black men have a 50% increased risk, with 1 in 6 men developing prostate cancer in their lifetime. While ...

  6. Breast cancer - Doctors and departments - Mayo Clinic

    cancer, Breast cancer, Head and neck cancer, Prostate cancer, Bladder cancer, Testicular cancer. Show more areas of focus for Carlos E. Vargas, M.D. ...

  7. Ram A. Pathak, M.D. - Doctors and Medical Staff - Mayo Clinic

    Ram A. Pathak, M.D., is a urologic oncologist at Mayo Clinic in Jacksonville, Florida specializing in prostate cancer diagnosis, MRI-guided biopsy, ...

  8. A Study Of Niraparib Combined With Abiraterone Acetate And Prednisone Versus Abiraterone Acetate And Prednisone To Treat Metastatic Prostate Cancer - Mayo Clinic

    A Study Of Niraparib Combined With Abiraterone Acetate And Prednisone Versus Abiraterone Acetate And Prednisone To Treat Metastatic Prostate Cancer. Print ...

  9. Efficacy Of [18F]PSMA-1007 PET/CT In Patients With Biochemial Recurrent Prostate Cancer - Mayo Clinic

    This study evaluates the diagnostic performance and safety of [18F]PSMA-1007 PET/CT imaging in patients with suspected recurrence of prostate cancer after ...

  10. Darolutamide (oral route) - Side effects & dosage - Mayo Clinic

    Darolutamide is used to treat patients with non-metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical ...